Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Early-stage Cancer
NCT07663396
Chemotherapy, Early Stage Cancer
Xining, Qinghai, China
View Trial DetailsNCT Number: NCT06711133
This study will enforce the role of ultrasound in early diagnosis and screening on peripheral neuropathy in comparison with other modalities.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Observational
Each case will undergo informed Written consent and will be told the aim of the study including benefits, no harm from this procedure to the participants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years
Enforce the role of ultrasound in screening and early detection of nerve affection in peripheral neuropathy in comparison with the traditional modalities as nerve biopsy and nerve conduction
Assiut University
Other
Role of Multimodal Ultrasonography in Evaluation of Peripheral Neuropathy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07663396
Chemotherapy, Early Stage Cancer
Xining, Qinghai, China
View Trial DetailsNCT07662863
Bladder Cancer, Carcinoma
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07644533
Advanced Cancer, Chemotherapy
Xining, Qinghai, China
View Trial DetailsNCT07639060
Arthritis, Autonomic Nervous System Diseases
View Trial Details